161. 家族性良性慢性天疱瘡 Familial benign chronic pemphigus Clinical trials / Disease details
臨床試験数 : 5 / 薬物数 : 9 - (DrugBank : 4) / 標的遺伝子数 : 2 - 標的パスウェイ数 : 24
Showing 1 to 5 of 5 diseases
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT05007223 (ClinicalTrials.gov) | May 8, 2020 | 5/8/2021 | Skin Microbiome Profile in Hailey-Hailey Disease | Characterization and Analysis of the Skin Microbiome in Hailey-Hailey Disease | Hailey-Hailey Disease | Drug: Doxycycline | Gangnam Severance Hospital | NULL | Completed | 19 Years | N/A | All | 18 | Korea, Republic of | |
2 | EUCTR2018-000373-80-FR (EUCTR) | 24/05/2018 | 13/03/2018 | A Phase 1/2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm Study of the Safety and Efficacy of LX3305, a Sphingosine-1-Phosphate Lyase Inhibitor, for Treatment of Darier’s Disease or Hailey-Hailey Disease A Phase 1/2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm Study of the Safety and Effi ... | A Phase 1/2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm Study of the Safety and Efficacy of LX3305, a Sphingosine-1-Phosphate Lyase Inhibitor, for Treatment of Darier’s Disease or Hailey-Hailey Disease - DERM-101 A Phase 1/2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm Study of the Safety and Effi ... | Darier’s Disease or Hailey-Hailey Disease MedDRA version: 20.0;Level: LLT;Classification code 10011860;Term: Darier's disease;System Organ Class: 100000004850 MedDRA version: 20.1;Classification code 10019029;Term: Hailey-Hailey disease;System Organ Class: 100000004850;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17] Darier’s Disease or Hailey-Hailey Disease MedDRA version: 20.0;Level: LLT;Classification code 100118 ... | Product Name: LX3305 250 mg capsule Product Code: LX3305 INN or Proposed INN: None Other descriptive name: (E)-1-(4-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone oxime Product Name: LX3305250 mg capsule Product Code: LX3305 INN or Proposed INN: None Other descriptive nam ... | Dermecular Therapeutics, Inc. | NULL | Not Recruiting | Female: yes Male: yes | 40 | Phase 1;Phase 2 | France | ||
3 | NCT02782702 (ClinicalTrials.gov) | September 2015 | 20/5/2016 | Evaluation of the Improvement of Quality of Life of Patients Suffering From Hailey Hailey or Darier Disease After Injections of Botulism Toxin Into Large Folds. Evaluation of the Improvement of Quality of Life of Patients Suffering From Hailey Hailey or Darier ... | Evaluation of the Improvement of Quality of Life of Patients Suffering From Hailey Hailey or Darier Disease After Injections of Botulism Toxin Into Large Folds. Toxin Hailey Darier Evaluation of the Improvement of Quality of Life of Patients Suffering From Hailey Hailey or Darier ... | Hailey-Hailey Disease;Darier Disease | Drug: Botulism Toxin Treatment | University Hospital, Toulouse | NULL | Completed | 18 Years | N/A | All | 30 | Phase 1 | NULL |
4 | EUCTR2013-004562-33-IT (EUCTR) | 17/12/2013 | 18/11/2013 | PHASE II STUDY TO EVALUATE SAFETY AND EFFICACY OF A BIO-RIASSORBABLE SUBCUTANEOUS IMPLANT OF AFAMELANOTIDE IN HAILEY-HAILEY DISEASE (HHD) PATIENTS PHASE II STUDY TO EVALUATE SAFETY AND EFFICACY OF A BIO-RIASSORBABLE SUBCUTANEOUS IMPLANT OF AFAMELA ... | PHASE II STUDY TO EVALUATE SAFETY AND EFFICACY OF A BIO-RIASSORBABLE SUBCUTANEOUS IMPLANT OF AFAMELANOTIDE IN HAILEY-HAILEY DISEASE (HHD) PATIENTS PHASE II STUDY TO EVALUATE SAFETY AND EFFICACY OF A BIO-RIASSORBABLE SUBCUTANEOUS IMPLANT OF AFAMELA ... | SYMPTOMATIC HHD PATIENTS MedDRA version: 16.1;Level: LLT;Classification code 10019029;Term: Hailey-Hailey disease;System Organ Class: 100000004850;Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16] SYMPTOMATIC HHD PATIENTS MedDRA version: 16.1;Level: LLT;Classification code 10019029;Term: Hailey-H ... | Trade Name: SCENESSE Product Name: SCENESSE | ISTITUTI FISIOTERAPICI OSPITALIERI | NULL | Authorised-recruitment may be ongoing or finished | Female: yes Male: yes | 10 | Phase 2 | Italy | ||
5 | JPRN-UMIN000010191 | 2013/04/01 | 01/04/2013 | The examination of the clinical response of celecoxib in Darier's disease and Hailey-Hailey disease | The examination of the clinical response of celecoxib in Darier's disease and Hailey-Hailey disease - The examination of the clinical response of celecoxib in Darier's disease and Hailey-Hailey disease The examination of the clinical response of celecoxib in Darier's disease and Hailey-Hailey disease- ... | Drier's disease Hailey-Hailey disease | celecoxib | Juntendo university gradurate school of medicine | NULL | Pending | 20years-old | Not applicable | Male and Female | 10 | Not selected | Japan |